Clinical Trial

Thoraflex Hybrid Post-Market Study

Study acronym: THOR
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a global, prospective non-interventional, multi-centre, post-market study of the Vascutek Thoraflex™ Hybrid system in patients with acute thoracic aortic syndrome, subacute/chronic dissection of the aorta and aortic aneurysm.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-01-23; most recent amendment 2025-07-04.
Status change: Recruiting → Active, Not Recruiting 2021-09-15
Status change: Not Yet Recruiting → Recruiting 2018-10-01
Trial Details
NCT Number NCT03414866
Lead Sponsor Vascutek Ltd.
Conditions Acute Aortic Dissection, Aortic Rupture, Penetrating Aortic Ulcer, Aortic Dissection, Aortic Aneurysm, Thoracic
Enrollment 182 participants
Start Date 2018-05-25
Primary Completion 2025-04-25 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-07-09